比较两种气道清除方法在COVID-19危重儿童和成人中的效果:一项先导性随机对照试验的研究方案结构化摘要
该研究为多中心前瞻性交叉非劣效性先导随机对照试验,拟在加拿大两所学术医院(一所儿童ICU、一所成人ICU)纳入50例机械通气的COVID-19患者。目的是探讨由非专业人员使用非侵入性振荡装置(NIOD)进行胸部物理治疗是否不劣于物理治疗师执行的标准胸部物理治疗(CPT),主要结局为操作前后氧合水平(SpO2/FiO2比值)。
要点
- 对于机械通气的COVID-19患者,NIOD由非专业人员操作可能不劣于物理治疗师执行的CPT。
- 主要结局为操作前后SpO2/FiO2比值,并在操作前、操作后10分钟和30分钟收集数据。
- 研究采用交叉设计,NIOD与CPT交替进行,间隔3小时。
核心结论
- 旨在探讨非专业人员使用NIOD进行胸部物理治疗是否不劣于物理治疗师执行的CPT,以减少医护人员暴露。
研究设计与样本
- 先导性多中心前瞻性交叉非劣效性随机对照试验,计划纳入50例机械通气的COVID-19患者(每臂25例)。
- 参与者来自加拿大两所学术医院的重症监护室(一所儿童ICU、一所成人ICU)。
- 随机化按年龄(>18岁或≤18岁)和研究地点分层,使用手工生成的随机数字和不透明密封信封。
- 不设盲。
关键数值与推荐
- 主要结局指标为操作前后氧合水平(SpO2/FiO2比值)。
- 样本量估计为每臂25例(总计50例),把握度0.90,α=0.05,非劣效性设计。
- NIOD和CPT交替进行,间隔3小时。
- 在操作前、操作后10分钟和30分钟收集数据。
临床怎么用
- 若NIOD不劣于CPT,可由非专业人员执行胸部物理治疗,减少物理治疗师和医护人员暴露于病毒的风险。
局限性
- 不设盲。
- 为先导性研究,样本量较小(50例)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: As there is no treatment for COVID-19 with a proven mortality benefit at this moment in the pandemic, supportive management including mechanical ventilation is the core management in an intensive care unit (ICU). It is a challenge to provide consistent care in this situation, highly demanding and leading to potential staff shortages in ICU. We need to reduce unnecessary exposure of healthcare workers to the virus. This study aims to examine the impact of care using a non-invasive oscillating device (NIOD) for chest physiotherapy in the care of mechanically ventilated patients with COVID-19. In particular, we aim to explore if a NIOD performed by non-specialized personnel is not inferior to the standard chest physiotherapy (CPT) undertaken by physiotherapists caring for patients with COVID-19. TRIAL DESIGN: A pilot multicenter prospective crossover noninferiority randomized controlled trial. PARTICIPANTS: All mechanically ventilated patients with COVID-19 admitted to one of the two ICUs, and CPT ordered by the responsible physician. The participants will be recruited from two intensive care units in Canadian Academic Hospitals (one pediatric and one adult ICU). INTERVENTION AND COMPARATOR: We will implement NIOD and CPT alternatingly for 3 h apart over 3 h. We will apply a pragmatic design, so that other procedures including hypertonic saline nebulization, intermittent positive pressure ventilation, suctioning (e.g., oral or nasal), or changing the ventilator settings or modality (i.e., increasing positive end-expiratory pressure or changing the nasal mask to total face continuous positive airway pressure) can be provided at the direction of bedside intensivists in charge. MAIN OUTCOMES: The primary outcome measurement is the oxygenation level before and after the procedure (SpO2/FiO2 ratio). For cases with invasive ventilation (i.e., the use of an endotracheal tube to deliver positive pressure) and non-invasive ventilation, we will also document expiratory tidal volume, vital signs, and any related complications such as vomiting, hypoxemia, or unexpected extubation. We will collect the data before, 10 min after, and 30 min after the procedure. RANDOMIZATION: The order of the procedures (i.e., NIOD or CPT) will be randomly allocated using manual generated random numbers for each case. Randomization will be carried out by the independent research assistant in the study coordinating center by using opaque sealed envelopes, assigning an equal number of cases to each intervention arm. Stratification will be applied for age (> 18 years or ≤ 18 years of age) and the study sites. BLINDING (MASKING): No blinding will be performed. NUMBERS TO BE RANDOMIZED (SAMPLE SIZE): We estimate the necessary sample size as 25 for each arm (total 50 cases), with a power of 0.90 and an alpha of 0.05, with a non-inferiority design. TRIAL STATUS: The protocol version number 1 was approved on 27 March 2020. Currently, recruitment has not yet started, with the start scheduled by the mid-June 2020 and the end anticipated by December 2020. TRIAL REGISTRATION: ClinicalTrials.gov NCT04361435 . Registered on 28 April 2020 FULL PROTOCOL: The full protocol is attached as an additional file, accessible from the Trials website (Additional File 1). In the interest in expediting dissemination of this material, the familiar formatting has been eliminated; this letter serves as a summary of the key elements of the full protocol.
引用
- Kawaguchi A, Bernier G, Lacroix J, et al. Comparison of two methods to clear the airways of critically ill children and adults with COVID-19 infection: a structured summary of a study protocol for a pilot randomized controlled trial. Trials. 2020. PMID: 32620174. doi:10.1186/s13063-020-04533-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。